Abstract | BACKGROUND: METHODS: Ninety-three patients were recruited in a 12-week single-blind randomized clinical trial, which was held between October 2009 and October 2010. Forty-three patients received olanzapine (5 mg/day) and 50 patients, haloperidol (2.5 mg/day). Before and after the study, they were evaluated by a speech pathologist by Van Riper's questionnaire. The data were analyzed using the SPSS version 16. T-test was used to compare the data between the two groups. RESULTS: CONCLUSIONS: It seems that olanzapine does have better impact in controlling stuttering, and it may be recommended to prescribe olanzapine for stutters as the first choice to control the stuttering under a careful follow-up.
|
Authors | Vahid Shaygannejad, Seyed Ahmadreza Khatoonabadi, Bijan Shafiei, Majid Ghasemi, Farzad Fatehi, Rokhsareh Meamar, Leila Dehghani |
Journal | International journal of preventive medicine
(Int J Prev Med)
Vol. 4
Issue Suppl 2
Pg. S270-3
(May 2013)
ISSN: 2008-7802 [Print] Iran |
PMID | 23776736
(Publication Type: Journal Article)
|